NIFTYSML50 Archives - ChartAlert®

AMBER – Amber Enterprises – Q4 FY26 Earnings Call – 18-May-26

AMBER/ Amber Enterprises’ topline growth remains robust (20%+ base case), but margin compression (50–100 bps) and working capital strain are near-term headwinds; long-term PCB leadership and Railway order book underpin structural upside.

1–2 minutes

Also see: AMBER – Amber Enterprises – Q4 FY26 Financial Results – 16-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Commodity inflation stabilizes (no further spikes), RDSO approvals on time, RAC industry grows 12–13%.
FY27 revenue grows ~20% (Electronics +40%, Railway +30%, Consumer Durables +12%). Margins compress 50–100 bps (partial pass-through). Net debt at INR 700–800 crores; capex cash outflow INR 1,100–1,200 crores. Ascent-K trial production Q3 FY28.

KAYNES – Kaynes Technology India – Q4 FY26 Earnings Call – 14-May-26

Kaynes Technology’s topline growth hinges on metering execution and OSAT/PCB scale, while margins and cash flows are structurally pressured by working capital and amortization until H2 FY27.

1–2 minutes

Also see: KAYNES – Kaynes Technology India – Q4 FY26 Financial Results – 13-May-26

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Metering receivables reduce 70% in 3 quarters, OSAT/PCB at guidance (INR550-700 crore), automotive grows at 10%.
Outcome: Revenue INR4,000-4,200 crore in FY27, EBITDA margins 15-16%, OCF breakeven by Q4 FY27. Diversification offsets cyclical weakness, but execution risks persist.

AMBER – Amber Enterprises – Q4 FY26 Financial Results – 16-May-26

Amber’s FY26 shows transformation from AC OEM to diversified electronics/defense, with 31% revenue share and Electronics EBITDA doubling. Risks: negative FCF, accelerating JV losses, ballooning WC. QIP/CCPS funding provides runway, but consolidated PAT margin inflection — not EBITDA alone — is the re‑rating trigger.

1–2 minutes

🔍 Observations

Topline

Revenue scaled 22.2% YoY to ₹12,186 Cr (FY26) from ₹9,973 Cr (FY25), driven by Electronics (+49%) and Consumer Durables (+14.6%) divisions.
Q4FY26 revenue of ₹4,148 Cr grew 10.5% YoY over Q4FY25’s ₹3,754 Cr, and 40.9% QoQ over Q3FY26 — strong seasonal peak execution.
Railway/Defense revenue grew 19% YoY to ₹535 Cr, still subscale at 4.4% of mix but directionally meaningful.

Bottomline

Reported PAT fell to ₹226 Cr (FY26) vs ₹251 Cr (FY25), distorted by ₹90 Cr JV losses and exceptional items net negative ₹-139 Cr; pre-exceptional, pre-JV operating profit rose.
EPS declined to ₹50.48 (FY26) from ₹72.01 (FY25) — partly mechanical dilution from QIP and CCPS issuance expanding share base.
Q4FY26 PAT of ₹162 Cr recovered sharply from Q3’s loss of ₹9 Cr, with exceptional gains of ₹60 Cr supporting the quarter.

Margins

EBITDA expanded to ₹1,072 Cr (FY26) vs ₹837 Cr (FY25) — EBITDA margin improved to 8.8% from 8.4% on ₹12,187 Cr revenue base. (Computed: EBITDA ₹1,07,248L / Revenue ₹12,18,648L)
Finance costs surged 36% YoY to ₹284 Cr, compressing PBT margin to 2.8% (FY26) vs 3.7% (FY25) despite EBITDA improvement.
Electronics segment EBITDA nearly doubled YoY (₹282 Cr vs ₹154 Cr), signalling strong operating leverage in the highest-growth division.

Growth Trajectory

Three-year compounding evident: Electronics grew 49% YoY, Railway/Defense 19% — both outpacing legacy Consumer Durables, reshaping mix favorably.
Acquisition of subsidiary (₹1,163 Cr outflow) and ₹1,295 Cr capex signal aggressive capacity build; growth is acquisition-led and capital-intensive.
Goodwill jumped from ₹361 Cr to ₹1,678 Cr YoY — acquisition accounting risk if acquired businesses underperform.

HINDCOPPER – Hindustan Copper – Q4 FY26 Financial Results – 15-May-26

Hindustan Copper’s FY26 delivered >₹3,000 Cr revenue, near‑doubling PAT, and ~1,050 bps margin expansion, with net‑cash balance sheet and >₹1,000 Cr FCF. Re‑rating hinges on mine expansion driving volume growth beyond LME tailwinds. Watch Q4 revenue concentration, ₹957 Cr “other expenses,” and copper price sensitivity for sustainability.

1–2 minutes

🔍 Observations

🔎 Observations

Topline

Revenue from operations surged 48.6% YoY (₹2,070.98 Cr → ₹3,077.92 Cr), with Q4FY26 alone contributing ₹1,156.08 Cr — 58% above Q4FY25’s ₹731.40 Cr, signalling a sharp H2 acceleration.
Q4FY26 sequential jump of 68.2% (₹687.34 Cr → ₹1,156.08 Cr) is outsized; likely driven by copper price tailwinds and volume ramp rather than structural demand alone.
Other income contracted marginally (₹77.27 Cr → ₹71.75 Cr), keeping total income growth anchored to operating performance.

Bottomline

Net profit nearly doubled — ₹487.42 Cr → ₹926.66 Cr (+90.1% YoY) — on pre-exceptional basis; EPS grew from ₹4.81 to ₹9.50.
Tax outgo more than doubled (₹164.98 Cr → ₹312.06 Cr), absorbing a significant portion of operating gains; effective tax rate ~25.3% vs ~26.1% prior year.
Q4FY26 PAT of ₹444.06 Cr — more than the entire H1FY26 — confirms steep back-loaded profit recognition.

Margins

EBITDA proxy (PBT before exceptional + depreciation + finance costs): FY26 = ₹1,328.47 + ₹200.44 + ₹4.01 = ₹1,532.92 Cr on revenue of ₹3,077.92 Cr → EBITDA margin ~49.8%; FY25: ₹632.40 + ₹175.58 + ₹6.93 = ₹814.91 Cr on ₹2,070.98 Cr → ~39.3%. A ~1,050 bps margin expansion YoY.
Net profit margin: FY26 = 926.66 / 3,077.92 = 30.1% vs FY25 = 487.42 / 2,070.98 = 23.5% — 660 bps improvement.
Cost of materials + stores + power as % of revenue: FY26 = (74.81 + 141.48 + 148.41) / 3,077.92 = 11.8% vs FY25 = (114.44 + 98.07 + 141.26) / 2,070.98 = 17.1% — operating leverage clearly kicking in.

Growth Trajectory

Revenue CAGR (1-year) of 48.6% and PAT CAGR of 90.1% are exceptional but likely contain LME copper price uplift — not purely volume-driven; sustainability hinges on commodity cycle.
Employee costs grew 14.8% (₹313.04 Cr → ₹359.40 Cr) and depreciation 14.2% (₹175.58 Cr → ₹200.44 Cr), both lagging revenue growth — positive operating leverage signal.
Other expenses jumped 26.3% (₹758.34 Cr → ₹957.38 Cr), a watch item; likely includes royalties, smelting charges, and mine-related costs scaling with volume.

KAYNES – Kaynes Technology India – Q4 FY26 Financial Results – 13-May-26

Kaynes’ FY26 shows 30%+ revenue compounding, margin expansion, and equity‑funded capex ahead of demand. PAT growth is suppressed by D&A and employee costs — growth investments, not inefficiencies. Risks: receivables at 42% of revenue with rising provisions. Margin inflection and re‑rating likely FY27–28, not immediate.

1–2 minutes

🔍 Observations

Topline

Revenue from operations surged to ₹36,264 Mn in FY26 vs ₹27,218 Mn in FY25 — a 33.2% YoY jump, with Q4 FY26 alone clocking ₹12,426 Mn (26.3% of full-year revenue), signalling accelerating execution.
Q4 FY26 revenue grew 26.2% YoY (₹9,845 Mn → ₹12,426 Mn) and 54.6% QoQ (₹8,040 Mn → ₹12,426 Mn), reflecting strong order deliveries in the quarter.
Other income of ₹1,568 Mn (FY26) vs ₹1,070 Mn (FY25) includes interest income of ₹1,011 Mn — notable, but the core revenue growth dominates the narrative.

Bottomline

Net profit grew 24.0% YoY — ₹3,639 Mn in FY26 vs ₹2,934 Mn in FY25 — lagging revenue growth due to elevated depreciation and a provision for doubtful debts of ₹782 Mn.
Q4 FY26 net profit of ₹912 Mn fell 21.5% YoY vs ₹1,162 Mn in Q4 FY25, driven by sharply higher D&A (₹544 Mn vs ₹169 Mn YoY) as new capex gets commissioned.
Basic EPS rose to ₹54.85 (FY26) from ₹45.82 (FY25), a 19.7% increase, slightly diluted by QIP-driven equity expansion.

Margins

EBITDA proxy (PBT before exceptional + D&A + Finance cost): ₹5,069 + ₹1,071 + ₹1,169 = ₹7,309 Mn on revenue of ₹36,264 Mn — EBITDA margin ~20.2% (FY25: ₹3,716 + ₹447 + ₹1,013 = ₹5,176 Mn on ₹27,218 Mn = 19.0%). Margin expansion of ~120 bps YoY.
Net profit margin compressed slightly: 10.0% (₹3,639/₹36,264) vs 10.8% (₹2,934/₹27,218) — the ₹782 Mn doubtful debt provision is the primary drag.
Material cost as % of revenue: ₹25,422 Mn / ₹36,264 Mn = 70.1% (FY25: ₹19,116 / ₹27,218 = 70.2%) — stable input cost structure despite scale-up.

Growth Trajectory

3-year CAGR is not computable from provided data, but FY26 marks the second consecutive year of ~30%+ revenue growth — a pattern consistent with strong order book execution in EMS.
Employee costs nearly doubled YoY (₹3,136 Mn vs ₹1,781 Mn), reflecting capacity and capability build for higher-complexity segments — dilutive near-term but value-accretive structurally.
D&A nearly tripled YoY (₹1,071 Mn vs ₹447 Mn), confirming aggressive asset commissioning; earnings growth will re-accelerate as utilisation improves.

LAURUSLABS – Laurus Labs Ltd – Q4 FY26 Earnings Call – 30-Apr-26

1–2 minutes

Also see: LAURUSLABS – Laurus Labs Ltd – Q4 FY26 Financial Results – 30-Apr-26

3-Scenario Framework

📊 Base Case (50% Probability)

CDMO grows 15–20% annually, with EBITDA margins at 26–28% as operating leverage offsets input costs. ARV revenue flat at INR 2,800 crore, reducing to <30% of total sales by FY27. Capex of INR 3,000 crore delivers ROCE of 15–17%. Key variables: Fermentation scale-up, non-ARV formulation growth.

LAURUSLABS – Laurus Labs Ltd – Q4 FY26 Financial Results – 30-Apr-26

Laurus Labs’ FY26 delivered 23% revenue, 151% PAT, and 170% OCF growth, reducing net debt despite capex. FCF of ₹554 Cr and Q4 EBITDA margin at 28.9% reinforce recovery. FY27 hinges on WC discipline, liability clarity, and CWIP conversion; triple‑digit PAT growth is unrepeatable.

1–2 minutes

🔍 Observations

Topline

Revenue scaled 22.7% YoY to ₹6,812.90 Cr (FY26 vs ₹5,553.96 Cr FY25), marking the strongest annual growth in recent cycles.
Q4 FY26 revenue of ₹1,811.57 Cr grew 5.3% YoY and 1.9% QoQ — sequential momentum is moderating but holding.
Full-year growth was broad-based within the single Pharmaceuticals segment; no sub-segment breakout is available.

Bottomline

PAT nearly tripled YoY: ₹889.85 Cr vs ₹354.41 Cr — a 151% jump driven by operating leverage and a 21% drop in finance costs (₹216 Cr → ₹170.73 Cr).
Q4 PAT of ₹281.91 Cr grew 20.5% YoY and 11.4% QoQ, confirming consistent quarterly earnings acceleration.
Effective tax rate held steady at ~24.7% (FY26 292.03 Cr on PBT of 1,181.88 Cr), providing no artificial PAT boost.

Margins

EBITDA margin expanded 650 bps YoY to 26.9% (FY26: ₹1,832.66 Cr vs FY25: ₹1,130.38 Cr on ₹5,553.96 Cr revenue); Q4 touched 28.9%, the cycle high.
PAT margin doubled from 6.5% to 13.1% — operating leverage amplified by deleveraging-driven interest savings.
Employee costs rose faster than revenue (24.5% YoY: ₹895.45 Cr vs ₹719.52 Cr), the one structural margin headwind to monitor.

Growth Trajectory

The PAT CAGR inflection is steep: ₹354 Cr → ₹890 Cr in one year signals a recovery cycle, not steady-state growth — base effects will moderate future YoY prints.
Capex stepped up sharply to ₹1,069.95 Cr (FY26) vs ₹641 Cr (FY25), signaling capacity investment for the next growth leg.
CWIP nearly doubled to ₹773.28 Cr vs ₹458.36 Cr — future depreciation drag is building; revenue from new assets is not yet visible.

AMBER – Q3 FY26 Earnings Call – 10-Feb-26

AMBER’s topline resilience (13–15% Consumer Durables, 79% Electronics growth) and margin expansion (Electronics double-digit FY27) hinge on execution of INR 6,800 Cr capex pipeline and commodity pass-through, with structural risks skewed to integration delays and cyclical RAC demand.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: RAC industry flattish (Amber +13–15%) + Unitronics synergies materialize (H2’27) + KCC/Hosur on schedule.
Outcome: 25–30% consolidated revenue growth, Electronics EBITDA 10–12%, Sidwal +40% YoY. Margins expand 50–100 bps on pass-through and volume leverage.

KAYNES – Q3 FY26 Earnings Call – 6-Feb-26

KAYNES’ topline hinges on project execution timing (Kavach, aerospace) and ODM adoption; bottomline sensitive to working capital normalization and subsidy-driven capex phasing; margins require ODM scale-up to sustain expansion beyond 16%. FY28 $1 billion target viable but contingent on structural ODM/OSAT execution.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Kavach executes in Q4; OSAT/PCB Phase 1 completes by FY27.
Outcome: FY26 revenue at INR 4,000 crore; EBITDA margin at 16% on throughput leverage. OCF turns positive in FY27 as receivables normalize. OSAT contributes INR 1,000 crore by FY28, PCB adds INR 800 crore; EMS grows at 25% CAGR. $1 billion FY28 revenue achieved, but margin expansion lags due to ODM ramp-up.

LAURUSLABS – Q3 FY26 Earnings Call – 23-Jan-26

LAURUSLABS: ARV-led generics and CDMO drive 15–25% growth, but biotech drag limits upside. EBITDA margins (26–28%) hinge on utilization and FX gains; ROCE recovery (18.5%→20–22%) rests on asset turnover. Gross margin at 60% needs ARV/CDMO mix, with risk of 55% under price pressure.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: CDMO grows 20% YoY (FY27), ARV stabilizes at ₹2,600 crore, peptide/ADC revenues commence in FY28 (~₹200–300 crore).
Outcome: Revenue CAGR of 18–22% (FY26–28), EBITDA margins at 26–28%, ROCE improves to 20–22%. CAPEX absorption drives asset turnover to 1.1x by FY28; net debt/EBITDA at 1.0–1.2x.